We rely on preclinical, translational, and clinical research to identify new and important ways of treating cancer. Our evolving pipeline is enhanced by the discoveries made through our relentless focus on bringing beneficial new drugs to patients and to the market.
Although cancer treatment remains a significant challenge, we are committed to pursuing hypothesis-based medicine in order to meet that challenge—and we have developed and are testing some very promising compounds.